Managed Healthcare Executive January 12, 2022
Keith Loria

But the future of value-based care in oncology is uncertain with no certain successor to the Oncology Care Model in sight.

The American Cancer Society estimated that by the end of 2021, 1.9 million new cancer cases will have been diagnosed and 608,570 cancer deaths will have occurred in the United States.

With many people worried about going to a doctor because of COVID-19, there is concern that a lack of cancer screenings may cause these numbers to rise in the years ahead. Paul Limburg, M.D., chief medical officer for screening at Exact Sciences and a professor of medicine at Mayo Clinic College of Medicine and Science in Rochester, Minnesota, expects that a big focus this year will be identifying...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Precision Medicine, Provider
Study shows growing cancer treatment inequities between high and low-income countries
California Sets 15% Goal for Primary Care Spending by 2034
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Hospitals continue to struggle with adverse events, medical errors
Providence announces new chief operating officer, and more | MED MOVES

Share This Article